Valuation: Euglena Co., Ltd.

Capitalization 56.95B 360M 305M 281M 266M 493M 33.34B 501M 3.29B 1.29B 16.16B 1.35B 1.32B P/E ratio 2026 *
146x
P/E ratio 2027 * 85.2x
Enterprise value 60.25B 381M 323M 297M 281M 521M 35.27B 530M 3.48B 1.36B 17.1B 1.43B 1.4B EV / Sales 2026 *
1.16x
EV / Sales 2027 * 1.07x
Free-Float
74.46%
Yield 2026 *
-
Yield 2027 * -
1 day-0.73%
1 week+1.74%
Current month+2.00%
1 month+5.68%
3 months+0.99%
6 months-6.41%
Current year+2.25%
1 week 397
Extreme 397
419
1 month 360
Extreme 360
421
Current year 356
Extreme 356
423
1 year 356
Extreme 356
513
3 years 356
Extreme 356
928
5 years 356
Extreme 356
1,108
10 years 356
Extreme 356
1,692
Manager TitleAgeSince
Chief Executive Officer 48 2023-12-31
President 46 2005-08-08
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Director/Board Member 46 2005-08-08
Director/Board Member 44 2018-11-30
Director/Board Member 59 2018-11-30
Change 5d. change 1-year change 3-years change Capi.($)
-0.73%+1.74%-9.31%-54.71% 360M
-3.80%-1.09%+68.01%+100.61% 16.3B
-3.32%+0.83%-21.74%+213.18% 6.71B
-0.36%+1.28%-2.38%-50.45% 2.73B
-0.55%+7.53%-78.51%-53.98% 1.89B
+5.26%+11.75%+164.29%+15.39% 1.76B
-1.69%-0.88%+20.64%-24.24% 1.61B
+1.18%+0.86% - - 1.52B
+2.41%+13.89%-68.13%-66.53% 1.08B
+1.06%+1.24%+9.85%+6.51% 1.04B
Average -0.05%+3.08%+9.19%+9.53% 3.5B
Weighted average by Cap. -2.13%-1.09%+31.77%+81.71%

Financials

2026 *2027 *
Net sales 51.9B 328M 278M 256M 242M 449M 30.38B 457M 3B 1.18B 14.73B 1.23B 1.21B 53.1B 336M 285M 262M 248M 459M 31.08B 467M 3.07B 1.2B 15.07B 1.26B 1.23B
Net income 380M 2.4M 2.04M 1.87M 1.77M 3.29M 222M 3.34M 21.94M 8.6M 108M 9.02M 8.83M 650M 4.11M 3.48M 3.2M 3.03M 5.62M 380M 5.72M 37.53M 14.72M 184M 15.42M 15.1M
Net Debt 3.3B 20.87M 17.68M 16.27M 15.4M 28.54M 1.93B 29.04M 191M 74.72M 936M 78.3M 76.67M 100M 633K 536K 493K 467K 865K 58.53M 880K 5.77M 2.26M 28.37M 2.37M 2.32M
Logo Euglena Co., Ltd.
euglena Co., Ltd. is a Japan-based company mainly engaged in the healthcare, energy and environmental business utilizing the research and development results on euglena. The Company masters the core technology of euglena, which provides the edibility of microalga euglena (Japanese name: Midorimushi) and the technology of outdoor large-scale cultivation. The Company operates in two business segments. The Healthcare segment is involved in the original equipment manufacturer (OEM) provision of food and cosmetics using euglena, as well as the planning and sale of products. The Energy and Environment segment is involved in the technology development and commissioned research of euglena and other microalgae, as well as the research and development of biofuels for the future commercialization.
Employees
793
Date Price Change Volume
26-04-17 409.00 ¥ -0.73% 539,800
26-04-16 412.00 ¥ -0.48% 959,800
26-04-15 414.00 ¥ +2.48% 1,271,600
26-04-14 404.00 ¥ 0.00% 715,900
26-04-13 404.00 ¥ +0.50% 679,700
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
409.00JPY
Average target price
400.00JPY
Spread / Average Target
-2.20%

Quarterly revenue - Rate of surprise